https://gpcr-compound-library.....com/index.php/bi-as-
For non-specific chemotherapy medicines, a lot of the first-line anticancer medicines do not have biomarkers to guide medical practitioner make therapy regimen. Furthermore, you will need to determine a long-term treatment solution on the basis of the person's genomic information during tumor advancement . Consequently, it's important to determine a tumor drug sensitiveness prediction design, that could help doctors in designing a personalized tumor treatment regime
Like
Comment
Share
